You are here

CIIID Awarded New Grant from the Seattle Foundation

CIIID Awarded New Grant from the Seattle Foundation

CIIID Awarded New Grant from the Seattle Foundation

The CIIID received funding today, December 22, 2015, from the Seattle Foundation to support the purchase of two essential pieces of equipment: an Ultra-Low Freezer and a Shaker incubator. The purchase of this equipment will support the infrastructure of the research activity of the CIIID’s Human Cell Signaling Core and the Innate Immune Mouse Transgenic Core.  Both of these Cores are unique in that they provide services to the UW biomedical research community in the area of innate immune research, in which the CIIID is uniquely focused.   The Human Cell Signaling Core and the Innate Immune Mouse Transgenic Core assist UW Medicine researchers to progress their understanding of how innate immunity impacts the clinical outcomes of a large number of diseases and to develop new therapeutics that use innate immune programming to provide clinical benefit to patients.

Recent News

On February 8th, the CIIID Education Core participated in Enumclaw’s 6th Annual STEM (Science Technology, Engineering, and Math) Expo. This event draws approximately 2,000 students and their families from all over the area to explore STEM concepts and careers.
The CIIID recently established a formal scientific partnership with Renji Hospital and Jiao Tong University Medical School in Shanghai, China.  CIIID Director, Dr. Michael Gale, Jr., and CIIID Associate Directors, Dr. Keith Elkon and Dr.
Immunologist Michael Gale Jr., ’8 5, ’94, and his team of scientists and students are focusing on a drug-like molecule that triggers a body's innate immunity to fight infection in a range of global pathogens including Zika, hepatitis C and West Nile.